Dr. Veraldi's research interests are in the molecular underpinnings of ILD. She studies mechanisms through which the heat shock response regulates the homeostatic balance of the extracellular matrix in an effort to define reversible -- and eventually treatable -- abnormalities that may contribute to the initiation and perpetuation of fibrosis. In addition to her clinical and scientific work as a member of the Simmons Center team, she is affiliated with the UPMC and University of Pittsburgh Scleroderma and Vasculitis Centers and serves as a sub-investigator for several NIH- and pharmaceutical company-sponsored clinical trials run through these three clinical centers of excellence.